Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ovarian Neoplasms

Free Subscription 04.06.2018 1 Am J Obstet Gynecol 1 BMC Cancer 2 Clin Cancer Res 1 Eur J Obstet Gynecol Reprod Biol 3 Gynecol Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Obstet Gynecol

1. HANLEY GE, Kwon JS, Finlayson SJ, Huntsman DG, et al
   Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: A cohort study from British Columbia, Canada.
   Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30429.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. LEE JY, Kim S, Kim YT, Lim MC, et al
   Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
   BMC Cancer. 2018;18:601.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

3. GRISHAM R, Moore KN, Gordon MS, Harb W, et al
   Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders.
   Clin Cancer Res. 2018 May 29. pii: 1078-0432.CCR-18-0494.
   PubMed     Text format     Abstract available
   
   
4. UUSI-KERTTULA H, Davies JA, Thompson J, Wongthida P, et al
   Ad5NULL-A20 - a tropism-modified, alphavbeta6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies.
   Clin Cancer Res. 2018 May 24. pii: 1078-0432.CCR-18-1089.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

5. POUNDS R, Phillips A, Kehoe S, Nevin J, et al
   Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention.
   Eur J Obstet Gynecol Reprod Biol. 2018;226:47-53.
   PubMed     Text format     Abstract available
   
   

   
   Gynecol Oncol

6. LINDEMANN K, Gao B, Mapagu C, Fereday S, et al
   Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
   Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30907.
   PubMed     Text format     Abstract available
   
   
7. GIANNOPOULOU L, Mastoraki S, Buderath P, Strati A, et al
   ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer.
   Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30922.
   PubMed     Text format     Abstract available
   
   
8. KOTSOPOULOS J, Gronwald J, Karlan B, Rosen B, et al
   Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.
   Gynecol Oncol. 2018 May 21. pii: S0090-8258(18)30898.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

9. HE X, Yang K, Wang H, Chen X, et al
   Expression and clinical significance of survivin in ovarian cancer: A meta-analysis.
   PLoS One. 2018;13:e0194463.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: